Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTH Gel in Rheumatoid Arthritis
NCT02030028Completed
- Sponsor
- Dana Ascherman
- Start
- Nov 2014
- Primary completion
- Jun 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of repository corticotropin injection in rheumatoid arthritis (RA), sponsored by Dana Ascherman. Primary endpoint: Clinical Disease Activity Index at 12 weeks. Started Nov 2014; status: completed.
02
Drugs
repository corticotropin injection
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02030028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02030028.